AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Subunit-adjuvanted influenza vaccine more immunogenic than split vaccine.

Vaccine Weekly

| April 09, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 APR 9 - (NewsRx.com & NewsRx.net) -- A subunit-adjuvanted influenza vaccine was more immunogenic in elderly subjects compared with an inactivated split virion influenza vaccine.

"A randomized, open study was carried out among an elderly population in order to compare the reactogenicity and immunogenicity of an inactivated, split virion influenza vaccine (Vaxigrip, Aventis Pasteur MSD, Lyon, France) with that of an MF59-adjuvanted, subunit vaccine (Fluad, Chiron Vaccines, Siena, Italy). Both vaccines contained the three strains: A/Sydney/5/97 (H3N2), A/Beijing/262/95 (H1N1), and B/Beijing/184/93, recommended by the WHO for the 1998-1999 influenza season," researchers in Italy report.

"A total of 2,150 subjects were vaccinated and included in the reactogenicity analysis," said S. Squarcione and collaborators at Osped Lazzaro Spallanzani and Aventis Pasteur MSD S.p.A. "A total of 1,076 subjects received Vaxigrip (age 73.3[+ or -]5.9 years, 49.6% men) and 1,074 subjects received Fluad(age 73.4[+ or -]5.9 years, 52.3% men). All subjects were kept under medical observation for 30 minutes after vaccination, in order to check any immediate local and/or systemic reaction. A self monitoring diary card was given to all subjects to collect any local and/or systemic reaction occurring during the three days following the vaccination, any adverse event occurring between vaccination day and 21st day post-vaccination and any medication taken during the study period."

"A total of 1,186 subjects were included in the immunogenicity analysis," the investigators reported. "A total of 591 subjects received Vaxigrip (age 73.4[+ or -]5.6 years, 52.3% men) and 595 subjects received Fluad (age 73.8[+ or -]5.9 years, 55.8% men). Blood samples were collected pre- and 21 days post-vaccination and were analyzed by the hemagglutination inhibition assay."

Squarcione and associates found, "In terms of reactogenicity both vaccines were generally well ...

Related articles from newspapers, magazines, journals, and more
Influenza vaccine with adjuvant more effective in elderly high-risk adults.
Newspaper article from: Biotech Week June 18, 2003 700+ words
...recently introduced MF59-adjuvanted influenza vaccine to determine its immunogenicity...effects from the MF59-adjuvanted influenza vaccine were reported, although...vaccine. "The MF59-adjuvanted influenza vaccine is more immunogenic...
Juvaris BioTherapeutics Initiates Phase 2 Study of Influenza Vaccine Adjuvant...
Press release article from: Business Wire November 2, 2009 700+ words
...to trivalent inactivated influenza vaccine administered with and without...cellular immunity) to the influenza vaccine. The study is also intended...States. "Developing an adjuvanted influenza vaccine to confer superior immunity...
Juvaris BioTherapeutics Begins Phase 2 Study of Influenza Vaccine Adjuvant in...
Magazine article from: Health & Beauty Close-Up November 4, 2009 700+ words
...to trivalent inactivated influenza vaccine administered with and without...cellular immunity) to the influenza vaccine. The study is also intended...States. "Developing an adjuvanted influenza vaccine to confer superior immunity...
European Mutual Recognition Approval of Chiron's Influenza Vaccine Fluad(R)...
Press release article from: PR Newswire May 24, 2000 700+ words
...Procedure to market its adjuvanted influenza vaccine Fluad(R) in 12 Western...largest segment of the influenza vaccine market. The vaccine contains...expands Chiron's European influenza vaccine portfolio, which includes...
Nanoemulsion-Based Intranasal Influenza Vaccine Adjuvant Triggers Robust...
Press release article from: PR Newswire October 27, 2008 700+ words
...administration of a novel, nasally delivered influenza vaccine elicited immune responses in ferrets that were...5, 15 and 45 micrograms of nanoemulsion- adjuvanted influenza vaccine (n=12 ferrets/dose). All three doses produced...
Chiron Announces Promising Data from Clinical Study of Adjuvanted Avian...
Press release article from: Business Wire October 28, 2005 700+ words
...ranged from 3.75 to 30 micrograms. "This study builds on the clinical data Chiron has already established with adjuvanted influenza vaccines," said Rino Rappuoli, Ph.D., chief scientific officer of Chiron and head of research for Chiron...
Publication No. WO/2009/109550 Published on Sept. 11, French Inventors Develop...
News wire article from: US Fed News Service, Including US State News September 16, 2009 700+ words
...adjuvanted vaccine composition in dry form and in particular a process for stabilizing an influenza vaccine composition, particularly an adjuvanted influenza vaccine composition in dry form." The invention carries International Patent Publication...
Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009...
Press release article from: PR Newswire August 1, 2008 700+ words
...aventis Group, began shipping influenza vaccine (Fluzone(R), Influenza Virus...The first 1.3 million doses of influenza vaccine began shipping this week following...completed in October. This year's influenza vaccine contains three new strains of the...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA